Laxmi Organic Industries Ltd Q1 FY27 Earnings Analysis

Published 31 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹4.2K Cr

Price

149

Market Cap

₹4.2K Cr

P/E Ratio

53.1

Revenue Rank

Rank 3

Margin Rank

Rank 3

Earnings Summary

- Dahej project's full impact on revenues to be seen from the second half of FY '27, with gradual ramp-up into FY '28 and beyond. - Phase 2 of Dahej is expected to commence operations in Q1 FY '27; Hitachi plant to start in Q2 FY '27. - Management expects Specialty business growth post-ramp-up of new capacities, especially from second half FY '27. - Revenue guidance shared: approx. - Laxmi Organic anticipates strong growth in FY '27 and beyond, driven by new capacities coming online, especially the Dahej Phase 2 and Hitachi projects.

📊 Revenue & Sales Performance

Rank 3

- Dahej project's full impact on revenues to be seen from the second half of FY '27, with gradual ramp-up into FY '28 and beyond. - Phase 2 of Dahej is expected to commence operations in Q1 FY '27; Hitachi plant to start in Q2 FY '27. - Management expects Specialty business growth post-ramp-up of new capacities, especially from second half FY '27. - Revenue guidance shared: approx. INR 3,700-4,000 crores in FY '27 and around INR 5,000 crores in FY '28. - Specialty segment growth depends on product ramp-up and contract fulfillment timelines. - Overall, the company is geared for growth, tapping controllable levers prudently and strengthening customer relations. - Cautious optimism owing to evolving chemical industry dynamics; exact numbers awaited as the situation stabilizes.

📈 Profitability & Margins

Rank 3

- Laxmi Organic anticipates strong growth in FY '27 and beyond, driven by new capacities coming online, especially the Dahej Phase 2 and Hitachi projects. - Dahej project (INR1,000 crore investment) revenue impact expected primarily in H2 FY '27 with gradual ramp-up into FY '28. - Hitachi plant to start quarter 3 FY '27, with steady qualification and ramp-up thereafter under a multiyear contract. - Specialty business expected to grow as deferred orders normalize and pricing stabilizes post-crisis. - Management is cautiously optimistic, focusing on prudent working capital management and judicious investment. - Exact financial numbers or EPS guidance were not provided due to volatile market conditions; management prefers to wait until situation stabilizes for clearer outlook. - Overall, the company is "geared for growth and to win," expecting improved revenues between INR3,700-4,000 crores in FY '27 and close to INR5,000 crores in FY '28.

🏗️ Capital Expenditure Plans

Yes

- Dahej project investment of approximately INR 1,000 crores, with asset turnover blending capex between Essentials and Specialties businesses. - Phase 2 of the Dahej plant chemical charging scheduled for Q1 FY '27, with sampling to customers starting thereafter; revenue impact expected from second half of FY '27. - Hitachi plant to commence operations in Q2 FY '27 with steady qualification and ramp-up planned; supported by a multiyear contract. - Post these projects' commissioning, no near-term capex planned, indicating the current capex cycle is largely complete. - Focus on judicious investment and working capital management to support growth. - Supply chain digitization project expected to go live in Q2 FY '27 to enhance operational efficiency. - Emphasis on responsible and sustainable manufacturing practices with improved water and energy intensity metrics.

💰 Fundraising & Capital Structure

No information

- There is no mention of any current or planned fundraising through debt or equity in the provided transcript. - The management discusses significant capital expenditure on the Dahej project (~INR 1,000 crores) and other capacity expansions. - The Dahej Phase 2 and Hitachi projects are expected to start operations around Q1 and Q2 FY '27 respectively, indicating ongoing investment but no new fundraising announcement. - The company emphasizes prudent working capital management, which supports investment in growth projects. - No direct references to new debt or equity fundraising plans were made during the call.

📋 Order Book & Pipeline

Yes

- Laxmi Organic Industries reported a good order book position as they entered FY '27, particularly at their fluorination setup at Lote. - The company has started dispatches from the new world-scale ethyl acetate setup line at Lote. - Phase 2 of the Dahej plant's chemical charging is set for Q1 FY '27, with sampling to customers starting then; revenues are expected from Dahej in the second half of FY '27. - They have multi-year contracts for some projects (e.g., Hitachi plant), with steady qualification and ramp-up underway. - The management emphasized a cautious yet optimistic ramp-up of ongoing projects and expects stronger revenue manifestation in FY '27 and beyond as capacities come online and order execution progresses.

Key Metrics

Revenue

Rank 3

Margin

Rank 3

Capex

Yes

Fundraise

No information

Order Book

Yes

Frequently Asked Questions

What were Laxmi Organic Industries Ltd Q1 FY27 results?

- Dahej project's full impact on revenues to be seen from the second half of FY '27, with gradual ramp-up into FY '28 and beyond. - Phase 2 of Dahej is expected to commence operations in Q1 FY '27; Hitachi plant to start in Q2 FY '27. - Management expects Specialty business growth post-ramp-up of new capacities, especially from second half FY '27. - Revenue guidance shared: approx. - Laxmi Organic anticipates strong growth in FY '27 and beyond, driven by new capacities coming online, especially the Dahej Phase 2 and Hitachi projects.

What is Laxmi Organic Industries Ltd share price analysis?

Laxmi Organic Industries Ltd currently shows a below-average growth signal. The stock trades at a P/E of 53.1 with a market cap of ₹4,227. Investors should review the full earnings analysis for detailed insights.

Is Laxmi Organic Industries Ltd planning capital expenditure?

- Dahej project investment of approximately INR 1,000 crores, with asset turnover blending capex between Essentials and Specialties businesses.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

Others in Chemicals & Petrochemicals this season

  • Aether Industries Ltd (Q1 FY27)

    Aether Industries Ltd Q1 FY27 quarterly results analysis. - Targeting 70% revenue from CRAMS and CEM and around 30% from Large Scale Manufacturing (LSM) in the

  • Sacheerome Ltd (Q1 FY27)

    Sacheerome Ltd Q1 FY27 quarterly results analysis. No information is provided regarding the same in the latest conference call. Market Cap ₹744, P/E 31.1. AI-po

  • Solar Industries India Ltd (Q1 FY27)

    Solar Industries India Ltd Q1 FY27 quarterly results analysis. - Targeting INR14,000 crores revenue in FY '27, marking strong growth from previous years. Market

  • SRF Ltd (Q1 FY27)

    SRF Ltd Q1 FY27 quarterly results analysis. No information is provided regarding the same in the latest conference call. Market Cap ₹79,723, P/E 41.9. AI-powere